TherapeuticsMD (NASDAQ: $TXMD) shares are trading higher after the company announced that it signed a definitive agreement with EW Healthcare Partners to get acquainted for $10 per share.

The board announced that it has unanimously approved the tender offer to acquire all outstanding shares of TXMD for $10 per share in a all cash transaction following its merger.

The purchase is a 367% higher per share offer from TXMD stock closed prices on May 27th.